New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
12:05 EDTNVO, GOOG, AAPL, GMCR, SNY, HD, NDAQ, HEK, REGN, BBRYOn The Fly: Midday Wrap
Stocks on Wall Street were slightly lower at midday with the averages moving in a narrow range as earnings season nears a close... ECONOMIC EVENTS: In the U.S., no major economic data was reported. In Europe, a meeting of finance ministers of the countries using the euro convened, with the strength of the shared currency, how to handle a bailout for Cyprus and progress in Greece likely to be discussed. In Asia, Chinese and Japanese markets were closed for holidays... COMPANY NEWS: Google (GOOG) slid about 1% after Chairman Eric Schmidt disclosed plans to sell 3.2M of the shares he holds, valued at $2.5B... Apple (AAPL) iPhones will replace Blackberry (BBRY) handsets for Home Depot (HD) managers and corporate staffers, according to a blog report. Shares of Apple rose nearly 2% amid that and the usual torrent of other news surrounding the world's biggest tech company, including rumors of a new "iWatch" that is under development. Its strength may have also been related to continued speculation around what, if anything, CEO Tim Cook may announce tomorrow in terms of plans to return capital to shareholders... MAJOR MOVERS: Among the notable gainers was Nasdaq (NDAQ), which jumped over 5% after Charles Gasparino of Fox Business said the company held "going private" talks with Carlyle Group (CG) that broke down but may resume. Also higher was Regeneron (REGN), which rose 4% after it disclosed that its partner Sanofi (SNY) plans to raises its stake by purchasing Regeneron shares. Sanofi was also higher by 3%, but that may have had more to do with the FDA directing Novo Nordisk (NVO) to carry out a new study on its competing insulin product prior to U.S. approval. Novo Nordisk shares fell 14% following the FDA decision. Also lower were shares of Heckmann (HEK), which declined 8% following a downgrade at Wedbush, and Green Mountain (GMCR), which slid 4% after a downgrade at Dougherty... INDICES: Near noon, the Dow was down 17.32, or 0.12%, to 13,975.65; the Nasdaq was down 2.60, or 0.08%, to 3,191.27; and the S&P 500 was down 0.65, or 0.04%, to 1,517.28.
News For NDAQ;AAPL;BBRY;HD;GOOG;REGN;SNY;NVO;HEK;GMCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>
March 17, 2015
07:28 EDTAAPLApple TV may provide boost for advertising unit, Business Insider says
Subscribe for More Information
06:50 EDTAAPLBanks unhappy with high Apple Pay fraud rates, NY Times says
Subscribe for More Information
06:37 EDTGOOG, AAPLAfter losing marketshare, Google now asks Firefox users to switch, BI says
Subscribe for More Information
05:58 EDTBBRYStocks with implied volatility above IV index mean;
Subscribe for More Information
05:57 EDTGOOG, AAPLChina vendors to ship 50M Androids with fingerprint sensors, DigiTimes reports
China vendors is expected to ship 50M Android (GOOG) smartphones with fingerprint sensors in 2015, reports DigiTimes. According to sources at Taiwan-based IC backend service companies, Android smartphone vendors have adopted sliding-type fingerprint sensors, which are more competitive in pricing compared to press-type sensors used by Apple (AAPL). Reference Link
05:46 EDTAAPLApple set to launch online TV service this year, Financial Times reports
Subscribe for More Information
05:40 EDTSNYSanofi upgraded to Outperform from Market Perform at Leerink
March 16, 2015
16:00 EDTAAPLOptions Update; March 16, 2015
Subscribe for More Information
15:24 EDTAAPLCablevision to provide HBO NOW via Optimum Online
Cablevision (CVC) and Time Warner's (TWX) Home Box Office announced that they have reached an agreement to offer standalone streaming service HBO NOW to Optimum Online customers via the internet. Optimum is the first cable provider to partner with HBO to offer the new service, which is expected to launch in April in time for the fifth season of Game of Thrones, the companies said. Cablevision plans to provide pricing and other particulars for HBO NOW in the coming weeks. Terms of the agreement were not disclosed. Apple (AAPL) and Time Warner announced on March 9 that HBO NOW will premier on Apple devices in April.
14:13 EDTAAPL, GOOGApple to offer Android users rebates to switch to iPhones, 9to5Mac says
Subscribe for More Information
11:20 EDTBBRYStocks with call strike movement; MNKD BBRY
Subscribe for More Information
10:44 EDTAAPLNetflix retreats after cut to sell on competition, cost concerns
The shares of Netflix (NFLX) are falling after research firm Evercore ISI downgraded the stock to Sell from Hold. Increased competition will force the company to increase its investments and the return from those investments is uncertain, the firm contends. WHAT'S NEW: In the U.S., technological advancements are enabling content providers to sell their programming to a wider range of Internet video distributors, Evercore ISI analyst Ken Sena wrote in a note to investors earlier today. Moreover, content providers themselves are now able to stream more of their programming online and obtain higher profits from doing so, Sena reported. The analyst noted that Apple (AAPL) recently obtained a three month exclusive deal to stream content form Time Warner's (TWX) HBO Now, while Yahoo (YHOO), Amazon (AMZN), and Hulu (DIS, CMCSA, NWSA) are all reportedly interested in obtaining streaming rights to "Seinfeld." Netflix's international expansion will not be sufficient to offset the increased competition, especially because foreign viewers are likely to watch less TV and be less interested in paying for TV content, the analyst believes. Furthermore, Netflix will face more competition from other Internet TV services overseas than in the U.S., according to Sena, who cut his 2015 consolidated operating income estimate for the company by 26% to $381M from $517M previously. In addition to cutting his rating, Sena lowered his price target on the shares to $380 from $450. PRICE ACTION: In early trading, Netflix sank $16, or 3.7%, to $422.
09:37 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:23 EDTSNY, REGNPCSK9 data continues to impress, says Leerink
Subscribe for More Information
07:16 EDTREGN, SNYRegeneron Sanofi dupilumab drug can generate $6B+ in revenue, says Bernstein
Bernstein believes that dupilumab, a drug made by Regeneron and Sanofi, has shown strong efficacy in patients with severe atopic dermatitis. The firm notes that the drug is currently in pivotal trials involving patients with severe levels of other common diseases. The firm thinks the drug can generate $1.5B of revenue by 2018 and $3.8B by 2020. Bernstein keeps a $500 price target and Outperform rating on Regeneron.
06:40 EDTSNY, REGNPCSK9 studies show potential improvement in heart health, WSJ says
Subscribe for More Information
06:07 EDTBBRYStocks with implied volatility above IV index mean; BBRY CZR
Subscribe for More Information
March 15, 2015
18:20 EDTAAPLApple's $17,000 watch looks over-priced, Barron's says
Subscribe for More Information
16:14 EDTBBRYBlackBerry collaborates with IBM, Samsung on SecuTABLET
Subscribe for More Information
13:04 EDTREGN, SNYSanofi, Regeneron announce publication of results of ODYSSEY long term trial
Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) today announced that 18-month results of a Phase 3 trial of Praluent, alirocumab, an investigational therapy, involving 2,341 high risk patients with hypercholesterolemia were published online in The New England Journal of Medicine. In the ODYSSEY LONG TERM trial, Praluent 150 mg every two weeks reduced low-density lipoprotein cholesterol by an additional 62% at week 24 when compared to placebo, the primary efficacy endpoint of the study, with consistent LDL-C lowering maintained over 78 weeks."These results demonstrated the durable efficacy for Praluent when added to maximally-tolerated statin therapy and further reinforce its generally consistent safety profile," said Jennifer Robinson, M.D., M.P.H., Director of the Prevention Intervention Center, Professor, Departments of Epidemiology & Medicine, College of Public Health at the University of Iowa. "Additionally, the post hoc analysis of major cardiovascular events represents an important finding for Praluent -- we look forward to results from the ongoing ODYSSEY OUTCOMES trial, which is prospectively evaluating the potential of Praluent to reduce cardiovascular events."
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use